Solomed Injection - High-Potency Parenteral Corticosteroid Therapy

Product Overview

Solomed Injection is a high-potency parenteral corticosteroid formulation containing Methylprednisolone (as Methylprednisolone Sodium Succinate / Acetate). Engineered for immediate systemic bioavailability via Intravenous (IV) injection/infusion or deep Intramuscular (IM) injection, Solomed provides rapid anti-inflammatory, immunosuppressive, and anti-allergic action during acute medical emergencies. It is indicated for the critical management of severe allergic reactions, anaphylaxis, severe acute asthma, acute exacerbations of multiple sclerosis, rheumatic disorders, status asthmaticus, and shock unresponsive to standard therapy.

Key Benefits

\n
• \n

  Rapid Anti-Inflammatory Action: Swiftly suppresses systemic inflammatory cascades in life-threatening and acute clinical situations.

  \n
\n
• \n

  Potent Immunosuppression: Rapidly attenuates hyperactive immune responses in autoimmune flares, organ transplant care, and severe allergic conditions.

  \n
\n
• \n

  High Glucocorticoid Activity: Delivers superior anti-inflammatory potency compared to hydrocortisone with minimal mineralocorticoid (salt-retaining) activity.

  \n
\n
• \n

  Emergency Life-Support Utility: Serves as a vital adjunct in anaphylactic shock, status asthmaticus, acute spinal cord injury protocols, and severe sepsis.

  \n
\n
• \n

  Flexible Parenteral Administration: Formulated for slow Intravenous (IV) direct injection, continuous IV infusion, or deep Intramuscular (IM) delivery.

  \n
\n

How It Works

Solomed Injection (Methylprednisolone) diffuses across cell membranes and binds with high affinity to specific intracellular glucocorticoid receptors. The receptor-steroid complex translocates into the cell nucleus, where it alters gene transcription. It upregulates anti-inflammatory proteins (like lipocortin-1) and represses pro-inflammatory cytokines (such as IL-1, IL-2, IL-6, and TNF-$\alpha$). Lipocortin inhibits phospholipase A2​, blocking the release of arachidonic acid and subsequently preventing the synthesis of inflammatory mediators including prostaglandins and leukotrienes.

Key Active Ingredients

\n
• \n

  Methylprednisolone (as Sodium Succinate / Acetate): Synthetic parenteral glucocorticoid providing powerful systemic anti-inflammatory and immunosuppressive activity.

  \n
\n

Directions for Use

\n
1. \n

   Reconstitution: Reconstitute the dry powder vial strictly with the provided sterile diluent (Bacteriostatic Water for Injection) prior to administration.

   \n
\n
2. \n

   Administration:

   \n \n
   \n
   • \n

     IV Injection/Infusion: Administer slowly over several minutes for direct bolus, or dilute in 0.9% Sodium Chloride / 5% Dextrose for IV infusion. High-dose pulse therapy must be infused over at least 30 to 60 minutes.

     \n
   \n
   • \n

     IM Injection: Administer via deep intramuscular injection into a large muscle mass (gluteal region).

     \n
   \n
   \n
\n
3. \n

   Clinical Dosing: Dosage varies widely depending on clinical indication and severity, ranging from 10mg to 500mg (or high-dose pulse therapy up to 1000mg/day), as determined by an attending physician.

   \n
\n
4. \n

   Professional Healthcare Use: Must be administered exclusively by a qualified healthcare professional in a hospital, clinic, or emergency setting.

   \n
\n

Precautions

\n
• \n

  Prescription-Only Parenteral: Strictly for professional healthcare administration; do not self-administer.

  \n
\n
• \n

  Rapid intravenous bolus injection of large doses (exceeding 0.5g or 1g) has been associated with cardiac arrhythmias and circulatory collapse; always adhere to recommended infusion rates.

  \n
\n
• \n

  Systemic corticosteroids can mask signs of infection and decrease resistance to localized or systemic viral, fungal, or bacterial infections.

  \n
\n
• \n

  Contraindicated in patients with systemic fungal infections or known hypersensitivity to methylprednisolone.

  \n
\n
• \n

  Long-term or repeated use requires gradual tapering of dosage to avoid acute adrenal insufficiency.

  \n
\n
• \n

  Consult an attending physician before use during pregnancy or lactation.

  \n
\n
• \n

  Keep out of reach of children.

  \n
\n

Storage Instructions

Store the un-reconstituted vial in a cool, dry place below 30°C, protected from light and heat. Once reconstituted, use immediately or store between 2°C and 8°C and use within 48 hours. Do not freeze.

Manufacturer Information

Formulated and manufactured in strict compliance with international pharmaceutical quality standards, dedicated to providing high-potency parenteral critical care and corticosteroid therapies that restore physiological stability and save lives.